Maat Pharma SA banner
M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 5.78 EUR 5.86%
Market Cap: €108.8m

Profitability Summary

Maat Pharma SA's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Maat Pharma SA

Margins Comparison
Maat Pharma SA Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
FR
Maat Pharma SA
PAR:MAAT
108.8m EUR
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
380.1B USD
Loading...
Loading...
Loading...
US
Exact Sciences Corp
NASDAQ:EXAS
362.4B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
190.4B USD
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
174.1B USD
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
113.6B USD
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.2B USD
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
68.5B AUD
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Maat Pharma SA Competitors

Country Company Market Cap ROE ROA ROCE ROIC
FR
Maat Pharma SA
PAR:MAAT
108.8m EUR
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
380.1B USD
Loading...
Loading...
Loading...
Loading...
US
Exact Sciences Corp
NASDAQ:EXAS
362.4B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
190.4B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
174.1B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
113.6B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.2B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
68.5B AUD
Loading...
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Maat Pharma SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett